- Home
- MLYS vs ACIC Comparison
MLYS vs ACIC Comparison
Compare MLYS & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- ACIC
- Stock Information
- Founded
- MLYS 2019
- ACIC 1999
- Country
- MLYS United States
- ACIC United States
- Employees
- MLYS N/A
- ACIC N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- ACIC Property-Casualty Insurers
- Sector
- MLYS Health Care
- ACIC Finance
- Exchange
- MLYS Nasdaq
- ACIC Nasdaq
- Market Cap
- MLYS 634.6M
- ACIC 632.9M
- IPO Year
- MLYS 2023
- ACIC N/A
- Fundamental
- Price
- MLYS $9.50
- ACIC $12.09
- Analyst Decision
- MLYS Strong Buy
- ACIC Buy
- Analyst Count
- MLYS 2
- ACIC 1
- Target Price
- MLYS $30.00
- ACIC $16.00
- AVG Volume (30 Days)
- MLYS 251.9K
- ACIC 189.3K
- Earning Date
- MLYS 11-11-2024
- ACIC 02-27-2025
- Dividend Yield
- MLYS N/A
- ACIC 4.13%
- EPS Growth
- MLYS N/A
- ACIC N/A
- EPS
- MLYS N/A
- ACIC 1.76
- Revenue
- MLYS N/A
- ACIC $290,784,000.00
- Revenue This Year
- MLYS N/A
- ACIC N/A
- Revenue Next Year
- MLYS N/A
- ACIC $12.68
- P/E Ratio
- MLYS N/A
- ACIC $6.88
- Revenue Growth
- MLYS N/A
- ACIC 1.02
- 52 Week Low
- MLYS $7.95
- ACIC $8.82
- 52 Week High
- MLYS $16.91
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- MLYS 33.43
- ACIC 39.75
- Support Level
- MLYS $8.60
- ACIC $11.59
- Resistance Level
- MLYS $9.97
- ACIC $12.87
- Average True Range (ATR)
- MLYS 0.89
- ACIC 0.50
- MACD
- MLYS -0.33
- ACIC -0.08
- Stochastic Oscillator
- MLYS 18.63
- ACIC 22.83
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.